Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations
- PMID: 16344511
- DOI: 10.1212/01.wnl.0000187116.13370.e0
Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations
Abstract
Background: Patients with Parkinson disease (PD) often experience visual hallucinations (VH) with retained insight (nonpsychotic) but the precise mechanism remains unclear.
Objective: To clarify which neural substrates participate in nonpsychotic VH in PD, the authors evaluated regional cerebral blood flow (rCBF) changes in patients with PD and VH.
Methods: The authors compared 24 patients with PD who had nonpsychotic VH (hallucinators) and 41 patients with PD who had never experienced VH (non-hallucinators) using SPECT images with N-isopropyl-p-[(123)I]iodoamphetamine. There were no significant differences in age, sex, duration of disease, doses of PD medications, Hoehn and Yahr scale, or Mini-Mental State Examination (MMSE) scores between the two groups. The rCBF data were analyzed using statistical parametric mapping (SPM).
Results: The rCBF in the right fusiform gyrus was lower in the hallucinators than in the non-hallucinators (corrected p < 0.05 at cluster levels). The hallucinators revealed higher rCBF in the right superior and middle temporal gyri than the non-hallucinators (uncorrected p < 0.001). These significant differences were demonstrated after MMSE scores and duration of disease, which are the relevant factors associated with VH, were covariated out.
Conclusions: Nonpsychotic visual hallucinations in Parkinson disease (PD) may be associated with hypoperfusion in the right fusiform gyrus and hyperperfusion in the right superior and middle temporal gyri. These temporal regions are important for visual object recognition and these regional cerebral blood flow changes are associated with inappropriate visual processing and are responsible for nonpsychotic visual hallucinations in PD.
Similar articles
-
Metabolic alterations in patients with Parkinson disease and visual hallucinations.Arch Neurol. 2007 Jul;64(7):984-8. doi: 10.1001/archneur.64.7.984. Arch Neurol. 2007. PMID: 17620488
-
Serotonin 2A receptors and visual hallucinations in Parkinson disease.Arch Neurol. 2010 Apr;67(4):416-21. doi: 10.1001/archneurol.2010.35. Arch Neurol. 2010. PMID: 20385906
-
Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.Parkinsonism Relat Disord. 2014 Apr;20(4):415-20. doi: 10.1016/j.parkreldis.2014.01.002. Epub 2014 Jan 13. Parkinsonism Relat Disord. 2014. PMID: 24467818
-
Attention and visual dysfunction in Parkinson's disease.Parkinsonism Relat Disord. 2012 Jul;18(6):742-7. doi: 10.1016/j.parkreldis.2012.03.004. Epub 2012 Apr 11. Parkinsonism Relat Disord. 2012. PMID: 22503538 Review.
-
Visual Hallucinations and Impaired Conscious Visual Perception in Parkinson Disease.J Geriatr Psychiatry Neurol. 2020 Nov;33(6):377-385. doi: 10.1177/0891988719892318. Epub 2019 Dec 6. J Geriatr Psychiatry Neurol. 2020. PMID: 31808354 Review.
Cited by
-
Mild Behavioral Impairment in Parkinson's Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects.Medicina (Kaunas). 2024 Jan 7;60(1):115. doi: 10.3390/medicina60010115. Medicina (Kaunas). 2024. PMID: 38256375 Free PMC article. Review.
-
Why psychosis is frequently associated with Parkinson's disease?Neural Regen Res. 2013 Sep 25;8(27):2548-56. doi: 10.3969/j.issn.1673-5374.2013.27.006. Neural Regen Res. 2013. PMID: 25206565 Free PMC article.
-
Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.Cogn Behav Neurol. 2008 Sep;21(3):143-9. doi: 10.1097/WNN.0b013e318185e698. Cogn Behav Neurol. 2008. PMID: 18797256 Free PMC article.
-
A whole-brain analysis in de novo Parkinson disease.AJNR Am J Neuroradiol. 2008 Apr;29(4):674-80. doi: 10.3174/ajnr.A0900. Epub 2008 Jan 9. AJNR Am J Neuroradiol. 2008. PMID: 18184843 Free PMC article.
-
Aberrant Amplitude of Low-Frequency Fluctuations in Different Frequency Bands in Patients With Parkinson's Disease.Front Aging Neurosci. 2020 Dec 3;12:576682. doi: 10.3389/fnagi.2020.576682. eCollection 2020. Front Aging Neurosci. 2020. PMID: 33343329 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical